PMC10272360_01
PMC10272360_02
MRI and [89Zr]Zr-crefmirlimab berdoxam PET/CT scans of cerebral lesion and pituitary gland.
fimmu-14-1199282-g001.jpg
PMC10272360_02_fimmu-14-1199282-g001.jpg
f1
Retrospective analyses of the [89Zr]Zr-crefmirlimab berdoxam PET scan showed an increase in tracer uptake in the pituitary gland after two cycles of combination treatment, from maximum standardized uptake value (SUVmax) 1.3 to SUVmax 3.7, suggesting treatment-induced increased infiltration of CD8+ T-cells ( Figure 1 ).